SCHEMBL16738093

SCHEMBL16738093

Cc1onc2c1-c1ccccc1NCC2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 4/20 0.61
BRD2 P25440 1/20 0.37
PTGS1 P23219 3/20 0.36
PTGS2 P35354 2/20 0.36
BCHE P06276 2/20 0.35
ACHE P22303 1/20 0.35
MAPT P10636 3/20 0.35
PLK1 P53350 1/20 0.34
NOS2 P35228 1/20 0.33
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
ALDH1A1 P00352 3/20 0.32
TSHR P16473 1/20 0.32
HSP90AB1 P08238 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
USP2 O75604 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16738078 0.76 BRD4 (1.00) BRD4BRD2BCHEACHENOS2
SCHEMBL16738088 0.74 PLK1 (0.41) BRD4PLK1
SCHEMBL16746013 0.71 BRD4 (0.51) BRD4BCHEACHEMAPTNOS2
SCHEMBL1495908 0.70 BRD4 (0.47) BRD4BCHEACHEMAPTNOS2
SCHEMBL1496025 0.68 BRD4 (0.44) BRD4BCHEACHEMAPTNOS2
SCHEMBL16745968 0.66 BRD4 (0.49) BRD4BCHEACHEMAPTNOS2
SCHEMBL11802702 0.65 BRD4 (0.44) BRD4BCHEACHEMAPTNOS2
SCHEMBL12657646 0.64 BRD4 (0.46) BRD4BCHEACHEMAPTNOS2
SCHEMBL4385099 0.64 BRD4 (0.40) BRD4BCHEACHEMAPTNOS2
SCHEMBL7255005 0.62 BRD4 (0.44) BRD4BCHEACHEMAPTNOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9624244-B2 Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof CONSTELLATION PHARMACEUTICALS, INC. (US) 2017-04-18 US disclosed
US-9624244-B2 Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof CONSTELLATION PHARMACEUTICALS, INC. (US) 2017-04-18 US disclosed
US-9624244-B2 Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof CONSTELLATION PHARMACEUTICALS, INC. (US) 2017-04-18 US disclosed
EP-2864336-B1 BENZO[B]ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS INC (US) 2016-11-23 EP disclosed
EP-2864336-B1 BENZO[B]ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS INC (US) 2016-11-23 EP disclosed
US-20150148333-A1 BENZO [B] ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS, INC. 2015-05-28 US disclosed
US-20150148333-A1 BENZO [B] ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS, INC. 2015-05-28 US disclosed
US-20150148333-A1 BENZO [B] ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS, INC. 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150148333-A1 BENZO [B] ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF BRD4, BRD3, BRD2 BRD4 1/4885BRD2 3/4885PTGS1 2895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.